The benefits of digital health interventions in cardiovascular disease
Join the ESC 2021 Satellite Symposium sponsored by WeHealthTM Digital Medicine with Chairpersons Martin Cowie (UK) and Andrew Coats (UK) on digital health interventions and their impact on prevention, diagnosis and treatment of cardiovascular conditions.
Key learnings:
- To ensure delegates are aware of current best practice in digital health as relevant to prevention, diagnosis and treatment of CV disease
- To provide practical examples of implementation of digital health into clinical practice
- To discuss how digital technologies can support better shared decision making between patients and their healthcare team
Agenda:
- 13:00 - 13:05
Introduction: Digital health and CVD prevention - natural partners
A. Coats (UK) - 13:05 - 13:12
Impact on prevention: role of telerehabilitation
M. Volterrani (ITA) - 13:12 - 13:20
Impact on diagnosis: role of AI in cardio-oncology
A. Lyon (UK) - 13:20 - 13:30
Impact on treatment adherence and disease stability
F. Köhler (GER) - 13:30 - 13:40
Panel discussion moderated by M. Cowie: How can we use new digital approaches to keep the patient at the center of decision making?
Andrew Coats, Nick Hartshorne-Evans, Friedrich Köhler, Alexander Lyon, Lis Neubeck, and Maurizio Volterrani. - 13:40 - 13:45
Conclusion: Open questions and perspectives
M. Cowie (UK)